Literature DB >> 11850785

Alternative lengthening of telomeres in mammalian cells.

Jeremy D Henson1, Axel A Neumann, Thomas R Yeager, Roger R Reddel.   

Abstract

Some immortalized mammalian cell lines and tumors maintain or increase the overall length of their telomeres in the absence of telomerase activity by one or more mechanisms referred to as alternative lengthening of telomeres (ALT). Characteristics of human ALT cells include great heterogeneity of telomere size (ranging from undetectable to abnormally long) within individual cells, and ALT-associated PML bodies (APBs) that contain extrachromosomal telomeric DNA, telomere-specific binding proteins, and proteins involved in DNA recombination and replication. Activation of ALT during immortalization involves recessive mutations in genes that are as yet unidentified. Repressors of ALT activity are present in normal cells and some telomerase-positive cells. Telomere length dynamics in ALT cells suggest a recombinational mechanism. Inter-telomeric copying occurs, consistent with a mechanism in which single-stranded DNA at one telomere terminus invades another telomere and uses it as a copy template resulting in net increase in telomeric sequence. It is possible that t-loops, linear and/or circular extrachromosomal telomeric DNA, and the proteins found in APBs, may be involved in the mechanism. ALT and telomerase activity can co-exist within cultured cells, and within tumors. The existence of ALT adds some complexity to proposed uses of telomere-related parameters in cancer diagnosis and prognosis, and poses challenges for the design of anticancer therapeutics designed to inhibit telomere maintenance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850785     DOI: 10.1038/sj.onc.1205058

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  219 in total

1.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Authors:  Sheila A Stewart; William C Hahn; Benjamin F O'Connor; Elisa N Banner; Ante S Lundberg; Poonam Modha; Hana Mizuno; Mary W Brooks; Mark Fleming; Drazen B Zimonjic; Nicholas C Popescu; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

2.  Mapping and initial analysis of human subtelomeric sequence assemblies.

Authors:  Harold Riethman; Anthony Ambrosini; Carlos Castaneda; Jeffrey Finklestein; Xue-Lan Hu; Uma Mudunuri; Sheila Paul; Jun Wei
Journal:  Genome Res       Date:  2004-01       Impact factor: 9.043

3.  Telomeres shorten more slowly in long-lived birds and mammals than in short-lived ones.

Authors:  Mark F Haussmann; David W Winkler; Kathleen M O'Reilly; Charles E Huntington; Ian C T Nisbet; Carol M Vleck
Journal:  Proc Biol Sci       Date:  2003-07-07       Impact factor: 5.349

4.  Telomerase extracurricular activities.

Authors:  Sandy Chang; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

5.  p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Authors:  Zaineb R Abdul Razak; Robert J Varkonyi; Michelle Kulp-McEliece; Corrado Caslini; Joseph R Testa; Maureen E Murphy; Dominique Broccoli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells.

Authors:  Susan M Bailey; Mark A Brenneman; Edwin H Goodwin
Journal:  Nucleic Acids Res       Date:  2004-07-16       Impact factor: 16.971

8.  Homolog-Dependent Repair Following Dicentric Chromosome Breakage in Drosophila melanogaster.

Authors:  Jayaram Bhandari; Travis Karg; Kent G Golic
Journal:  Genetics       Date:  2019-05-03       Impact factor: 4.562

Review 9.  Cellular lifespan and regenerative medicine.

Authors:  Thomas Petersen; Laura Niklason
Journal:  Biomaterials       Date:  2007-05-25       Impact factor: 12.479

10.  Increased hTR expression during transition from adenoma to carcinoma is not associated with promoter methylation.

Authors:  Atsuo Nakamura; Takeshi Suda; Terasu Honma; Toru Takahashi; Masato Igarashi; Nobuo Waguri; Hirokazu Kawai; Yusaku Mita; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.